Trial intelligence / Profile preview

Excimer laser vs clobetasol propionate in prurigo form of atopic dermatitis

2006-005602-31Phase 4Active

Sponsor
Academic Medical Center
Start
Oct 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of clobetasol in atopic dermatitis (AD) (2 arms), sponsored by Academic Medical Center. Primary endpoint: Primary efficacy of excimer laser in prurigo form of atopic dermatitis. Started Oct 2006; status: active.

02

Drugs

clobetasol
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on 2006-005602-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-005602-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call